4.6 Review

The Multifaceted Biology of PCSK9

期刊

ENDOCRINE REVIEWS
卷 43, 期 3, 页码 558-582

出版社

ENDOCRINE SOC
DOI: 10.1210/endrev/bnab035

关键词

beta-cells; cancer/metastases; hypercholesterolemia; major histocompatibility complex I; sepsis

资金

  1. Canadian Institutes of Health Research Foundation Scheme grant [148363]
  2. Canada Chair in Precursor Proteolysis [950-231335]

向作者/读者索取更多资源

This article reviews the discovery, structure-function characteristics, and novel biological functions of PCSK9. The critical function of PCSK9 is to increase LDL-cholesterol levels by enhancing LDLR sorting and escort to lysosomes. Recent studies have extended our understanding of PCSK9's biological functions, including implications in septic shock, vascular inflammation, viral infections, and immune checkpoint modulation in cancer.
This article reviews the discovery of PCSK9, its structure-function characteristics, and its presently known and proposed novel biological functions. The major critical function of PCSK9 deduced from human and mouse studies, as well as cellular and structural analyses, is its role in increasing the levels of circulating low-density lipoprotein (LDL)-cholesterol (LDLc), via its ability to enhance the sorting and escort of the cell surface LDL receptor (LDLR) to lysosomes. This implicates the binding of the catalytic domain of PCSK9 to the EGF-A domain of the LDLR. This also requires the presence of the C-terminal Cys/His-rich domain, its binding to the secreted cytosolic cyclase associated protein 1, and possibly another membrane-bound protein X. Curiously, in PCSK9-deficient mice, an alternative to the downregulation of the surface levels of the LDLR by PCSK9 is taking place in the liver of female mice in a 173-estradiol-dependent manner by still an unknown mechanism. Recent studies have extended our understanding of the biological functions of PCSK9, namely its implication in septic shock, vascular inflammation, viral infections (Dengue; SARS-CoV-2) or immune checkpoint modulation in cancer via the regulation of the cell surface levels of theT-cell receptor and MHC-I, which govern the antitumoral activity of CD8+T cells. Because PCSK9 inhibition may be advantageous in these processes, the availability of injectable safe PCSK9 inhibitors that reduces by 50% to 60% LDLc above the effect of statins is highly valuable. Indeed, injectable PCSK9 monoclonal antibody or small interfering RNA could be added to current immunotherapies in cancer/metastasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据